Bacillus Clausii, Coagulans and Subtilis: Bugs With BenefitsThree spore-forming Bacillus probiotics, what human trials found for each, and who should ask a doctor first.

You've probably spent a good part of your life trying to get rid of germs. Sanitiser at the door. Antibacterial soap by the sink. That one aunt who boils everything twice, just to be sure.

So here's a plot twist: some bacteria are on your side. Right now, your gut is home to a bustling city of microbes (we gave them a full tour in how your gut microbiome works). Some are like personal assistants who help break down your food. Others are more like that noisy neighbour you'd rather not have. The trick, as with most things in life, is balance.

Which brings us to probiotics, and to three names you'll keep meeting on Indian pharmacy shelves and supplement packs: Bacillus clausii, Bacillus coagulans and Bacillus subtilis. What are they? Do they actually work? And who should skip them? Let's dig in. (Gut pun fully intended.)

What is a probiotic?

A probiotic is a live microorganism that gives you a health benefit when you take it in adequate amounts. That's the FAO/WHO definition, which an international expert panel reconfirmed in 2014.¹ Each part of it matters:

• Live. Dead bacteria don't count as probiotics.
• Adequate amounts. A tiny sprinkle won't cut it. Dose matters.
• Health benefit. There should be real evidence, ideally from human studies, that it helps.

One more thing: probiotics are picky about their strain, the specific "individual" within a species. The US National Institutes of Health puts it plainly: if one kind of Lactobacillus helps, that doesn't mean another kind will.² Even how well a spore-former survives your gut can differ from strain to strain.³ Think of the species as the family name and the strain as the person. Two cousins can share a surname and still be completely different people.

The right bacteria, in the right amount, with real proof that it helps. Anything less is just a nice label.

How Bacillus probiotics survive stomach acid

Bacillus probiotics survive stomach acid by travelling as spores, a dormant form with a tough coat that can handle the stomach's extreme acidity and tolerate bile salts.⁴

Your stomach is a terrible commute

Before a probiotic can do anything useful, it has to survive the trip through stomach acid and a splash of bile. It's the microbial equivalent of Mumbai traffic in the monsoon.

Most classic yoghurt-type probiotics, the Lactobacillus kind in curd, don't form spores, so they make that journey unprotected (the full showdown is in our Bacillus vs Lactobacillus comparison). So the real question isn't just "how many bacteria are in this?" It's how many will actually make it to the finish line?

Bacillus comes with a shield

A Bacillus bacterium can pack itself into a dormant, tough-coated spore. Think of a seed, or a bear hibernating inside a bunker. That bunker carries it through the acid and the bile, and it also keeps Bacillus more stable through processing and storage.⁴

What happens once they arrive?

They wake up, get to work, and then move on. In a mouse study, Bacillus subtilis spores germinated ("woke up") in significant numbers in the small intestine and appeared to settle there, albeit briefly.⁵ In people, a single dose of B. clausii spores survived the whole trip: live B. clausii turned up in volunteers' stool for up to 12 days, and in some volunteers more of certain strains came out than went in, a sign they had multiplied along the way.³ Researchers call this transient colonisation.⁴ Visitors, not permanent residents: the human trials below gave them daily.

Bacillus clausii uses: meet the Bodyguard

Bacillus clausii is mostly used, and mostly studied, alongside medical treatment: for acute diarrhoea in children, where six trials together found it shortened episodes by about 9 hours, and to ease gut side effects during antibiotics.^6,7 It has the most human evidence of the three, much of it company-linked.

The Bodyguard. Tough enough to stand up to some antibiotics, which is exactly how it made its name.

In India you'll mostly meet it at the chemist, as small vials of spore suspension; an Indian lab test of 11 such products found their quality varied widely.⁸ Several B. clausii strains resist chloramphenicol and tetracycline, which is why the suspension is used alongside antibiotics.⁴ And if a label says Alkalihalobacillus clausii, same bug, new name.⁹

What the research says.

• Children's diarrhoea. A 2018 meta-analysis of 6 randomised trials (1,298 children) found B. clausii cut diarrhoea by about 9 hours and hospital stays by about 0.85 days compared with control; stool frequency only trended lower. One author works for Sanofi.⁶ An Asian expert panel, Indian paediatricians included, all with Sanofi consultancy fees, backs it as an add-on to oral rehydration solution (ORS) for acute viral diarrhoea.¹⁰ ORS stays the main event.
• During antibiotics. In 120 people on a week of triple therapy for H. pylori, B. clausii (2 billion spores three times a day for 14 days) lowered nausea, diarrhoea and upper-stomach pain compared with placebo, without changing whether the infection cleared.⁷ An Indian trial of a different strain, 088AE, in 120 children and adults on antibiotics (4 billion a day for ages 2 to 10, 6 billion for 11 to 65, for 7 days) lowered diarrhoea severity; both authors work in a company's probiotics lab.⁹
• IBD. At AIIMS, New Delhi, people with inflammatory bowel disease (IBD), a long-term condition where the gut lining stays inflamed, took strain UBBC-07 or a placebo for four weeks, alongside their usual treatment. The researchers reported no adverse events, more Lactobacillus, Bifidobacterium and Faecalibacterium, a rise in the anti-inflammatory messenger IL-10 and lower symptom scores.¹¹ The abstract gives no patient numbers, and two authors work for the probiotic maker Unique Biotech, so treat it as an early signal, not a verdict.

Bacillus coagulans benefits: meet the Undercover Agent

Bacillus coagulans benefits are best studied in adults with IBS, where one strain, Unique IS2, eased abdominal pain at 2 billion CFU a day, a result an independent meta-analysis has since backed.^12,13 In children's diarrhoea the results are split, which says a lot about strain names.

The Undercover Agent. Makes lactic acid like yoghurt bacteria, but travels in armour like a true Bacillus.

B. coagulans has a slightly confusing backstory. That mix of lactic acid and spores had it mislabelled "Lactobacillus sporogenes", a name still widely used in India.⁴ Some newer papers call it Weizmannia coagulans.¹⁴

What the research says.

• IBS and regularity. In 2019, 136 adults with irritable bowel syndrome (IBS), that frustrating mix of cramps, bloating and unpredictable bathroom trips, took B. coagulans Unique IS2 (2 billion CFU a day) or a placebo for eight weeks. The probiotic group reported less abdominal pain and discomfort and more complete spontaneous bowel movements, with no serious side effects. Three authors work for the strain's maker.¹² An independent 2026 strain-by-strain meta-analysis agrees that Unique IS2 improved key IBS symptoms.¹³ A 2025 trial in 144 healthy adults with infrequent bowel movements found it made stools more frequent and softer, though gut symptoms didn't change.¹⁵
• Children's diarrhoea, two answers. In 110 children aged 1 to 10, strain MTCC 5856 (400 million spores a day for 5 days, with ORS and zinc) cut diarrhoea from about 63 to 51 hours; six authors work for the company Sami-Sabinsa.¹⁴ But at the National Institute of Cholera and Enteric Diseases in Kolkata, a trial in 148 children aged 6 to 24 months with dehydrating diarrhoea found "Lactobacillus sporogenes" tablets made no difference to recovery, duration or volume.¹⁶ Different strain, age and illness. Same species name on the pack.

And IBS is a medical diagnosis: this is what particular strains did in trials, not a reason to skip the gastroenterologist.

Bacillus subtilis as a probiotic: meet the Multitasker

Bacillus subtilis has the thinnest human evidence of the three: two recent gas-and-bloating trials on different strains, one positive and one mostly negative.^17,18

The Multitasker. A promising all-rounder, still auditioning in people.

Does it do anything you'd actually feel? In a 2022 trial, 76 healthy adults took B. subtilis BS50 (2 billion CFU a day) or a placebo for six weeks. On a combined score for bloating, burping and gas, 47.4% of the BS50 group improved, against 22.2% on placebo. Burping on its own improved significantly (44.7% vs 22.2%); bloating moved the same way (31.6% vs 13.9%), but that difference was not statistically significant. The strain's maker funded the study and helped design it.¹⁷ In other words: fewer "excuse me" moments, in one trial.

Then the sequel. In 100 adults with functional bloating, a different strain, ATCC 122264, at 5 billion CFU a day for 8 weeks did no better than placebo on overall gas symptoms; only in a subgroup analysis did women report less belching and flatulence. Two of its authors work for the ingredients company Kerry.¹⁸ Both strains were well tolerated.

Does Bacillus work? The verdict at a glance

Sometimes, for specific strains in specific people. Of the ten human studies below, eight found a benefit on their main measures and two found none, and eight of the ten had company funding or company-employed authors, per their abstracts. Not a reason to dismiss them; a reason to read the strain code.

Probiotic side effects: usually mild, rarely serious

The usual probiotic side effects are mild gut ones: Indian pharmacy information for B. clausii lists bloating and flatulence,¹⁹ and in the trials above the strains were well tolerated. The serious risk is the bacteria getting into the bloodstream, reported mostly in people with weak immunity, the critically ill, newborns and the elderly.⁴

Trials report safety inconsistently, and case reports describe systemic infections among the possible risks.²⁰ For Bacillus probiotics, they look like this:

• A 17-month-old with no underlying illness had B. clausii in the blood for 111 days after brief probiotic use; the authors found seven earlier prolonged cases, all in people with other illnesses.²¹
• A malnourished 4-month-old with severe diarrhoea was given a B. clausii suspension, developed sepsis from it alongside two other infections, and died of multi-organ failure.²²
• Among 16,436 children who had heart surgery in China, 5,034 were given probiotics, and 6 developed bacteraemia with probiotic bacteria, B. subtilis among them. Three hadn't taken probiotics themselves; all six had central venous lines and all cleared with antibiotics.²³

What's in the vial is a risk too. Some probiotic products contain microbes that aren't on the label.² Of the 11 B. clausii products tested in India, contaminants turned up in all but two, and two of them carried Bacillus cereus. Antibiotic resistance varied too: one product resisted every antibiotic tested, while most of the others resisted none. Two of the authors work for the company behind the study's reference product.⁸

Who should ask a doctor first

Check with a doctor before any probiotic if you have a weakened immune system or a serious illness, because the risk of harm is higher.² The same goes for anyone with a central line or a damaged gut lining,²⁴ and for premature babies, where severe and fatal infections have been reported.² If you're pregnant, breastfeeding or on medication, ask first too. And for a child with diarrhoea, oral rehydration solution comes first;^10,14 anything else should be the doctor's call.

How to read a Bacillus probiotic label

A good Bacillus probiotic label names the species and strain codes and gives a CFU count per serving, so you can match it to a trial. If you're buying one, or comparing probiotic brands in India, check these:

• Names, not buzzwords. "Bacillus coagulans" tells you the family. The code after it (Unique IS2, MTCC 5856, UBBC-07, 088AE) tells you which trials apply.
• Check the dose. The adult trials above that give a dose used 2 to 6 billion CFU (colony-forming units) a day.^7,12,17 No CFU on the pack? Red flag.
• Match the person. A trial in toddlers with diarrhoea says little about an adult with bloating.
• Check the maker. Given the Indian contamination findings, favour brands that say exactly what's inside and publish their certificates.
• Feed your good bugs. Bacteria need fibre: fruits, vegetables, dals, whole grains, or a gentle add-on (we compared two in PHGG vs psyllium fibre).
• Be consistent. Spores pass through, and the trials gave them daily, not once.

Where SILT lands

SILT Mornings brings all three species, B. subtilis, B. coagulans and B. clausii, together at 2 billion CFU each, 6 billion CFU a stick, alongside 5 g of Sunfiber® PHGG fibre. Spores were the point: they hold up in a powder, and in your stomach, better than fragile cultures do.⁴

Two honest caveats. The pack names the species, not strain codes, so Mornings may not contain the strains tested above, and its doses may differ; read those results as what the research found, not as what SILT does. And SILT is an everyday food supplement for gut, energy and nutrition; it doesn't treat IBS, IBD, diarrhoea or any other condition. For those, talk to your doctor. If you take a blood thinner such as warfarin, ask your doctor before using SILT Mornings, because it contains vitamin K2 (55 mcg). What we can promise is the label: every dose printed, no proprietary blends, and a certificates of analysis for our ingredients.

Trust your gut. Better still, back it up.

B. clausii guards, B. coagulans goes undercover, B. subtilis multitasks. But the real lesson from ten studies is the boring one: trust the strain, not the species. Not bad for a bunch of bugs, right?

References

1. Hill C, Guarner F, Reid G, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66
2. National Center for Complementary and Integrative Health (US National Institutes of Health). Probiotics: usefulness and safety. nccih.nih.gov/health/probiotics-usefulness-and-safety
3. Ghelardi E, Celandroni F, Salvetti S, Gueye SA, Lupetti A, Senesi S. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology. 2015;119(2):552–559. doi:10.1111/jam.12848
4. Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Frontiers in Microbiology. 2017;8:1490. doi:10.3389/fmicb.2017.01490
5. Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Applied and Environmental Microbiology. 2002;68(5):2344–2352. doi:10.1128/AEM.68.5.2344-2352.2002
6. Ianiro G, Rizzatti G, Plomer M, et al. Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2018;10(8):1074. doi:10.3390/nu10081074
7. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Alimentary Pharmacology & Therapeutics. 2004;20(10):1181–1188. doi:10.1111/j.1365-2036.2004.02274.x
8. Kesavelu D, Ganpathy S, Jog P, Acharya B, Saxena V, Telang N, Gaikwad N. Evaluating the compositional quality of probiotics containing Bacillus clausii in India. Advances in Therapy. 2025;42(9):4571–4582. doi:10.1007/s12325-025-03289-2
9. Maity C, Gupta AK. Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: a randomized controlled trial. Heliyon. 2021;7(9):e07993. doi:10.1016/j.heliyon.2021.e07993
10. De Castro JA, Kesavelu D, Lahiri KR, et al. Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic Bacillus clausii (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts. Tropical Diseases, Travel Medicine and Vaccines. 2020;6:21. doi:10.1186/s40794-020-00120-4
11. Bamola VD, Dubey D, Samanta P, Kedia S, Ahuja V, Madempudi RS, Neelamraju J, Chaudhry R. Role of a probiotic strain in the modulation of gut microbiota and cytokines in inflammatory bowel disease. Anaerobe. 2022;78:102652. doi:10.1016/j.anaerobe.2022.102652
12. Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Scientific Reports. 2019;9:12210. doi:10.1038/s41598-019-48554-x
13. Maslennikov R, Gosteeva E, Ananeva V, et al. Strain-specific systematic review with meta-analysis of probiotics efficacy in the treatment of irritable bowel syndrome. Journal of Clinical Medicine. 2026;15(3):1152. doi:10.3390/jcm15031152
14. Majeed M, Nagabhushanam K, Arumugam S, et al. Probiotic Weizmannia coagulans MTCC 5856 as adjunct therapy in children's acute diarrhea: a randomized, double-blind, placebo-controlled study. Frontiers in Pediatrics. 2024;11:1338126. doi:10.3389/fped.2023.1338126
15. LeMoire A, Replogle R, Shinn L, et al. Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial. Beneficial Microbes. 2025;16(5):533–543. doi:10.1163/18762891-bja00072
16. Dutta P, Mitra U, Dutta S, Rajendran K, Saha TK, Chatterjee MK. Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as probiotic in clinical practice, on acute watery diarrhoea in children. Tropical Medicine & International Health. 2011;16(5):555–561. doi:10.1111/j.1365-3156.2011.02745.x
17. Garvey SM, Mah E, Blonquist TM, Kaden VN, Spears JL. The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial. Gut Microbes. 2022;14(1):2122668. doi:10.1080/19490976.2022.2122668
18. LeMoire A, Lin L, Girard SA, et al. Effect of Bacillus subtilis ATCC 122264 on intestinal gas symptoms and quality of life in adults with functional bloating. Beneficial Microbes. 2025;16(3):281–292. doi:10.1163/18762891-bja00057
19. 1mg. Bacillus clausii: uses, side effects and medicines (generic information page, last updated 14 January 2026; checked 8 October 2026). Not linked: SILT does not link to retailers.
20. Doron S, Snydman DR. Risk and safety of probiotics. Clinical Infectious Diseases. 2015;60(Suppl 2):S129–S134. doi:10.1093/cid/civ085
21. Khatri AM, Rai S, Shank C, et al. A tale of caution: prolonged Bacillus clausii bacteraemia after probiotic use in an immunocompetent child. Access Microbiology. 2021;3(3):000205. doi:10.1099/acmi.0.000205
22. Muñoz M, Castaño GE, Esquivel Suman R, Alvarado M. Septicemia due to Bacillus clausii after the use of probiotics. A complication to keep in mind. Andes Pediatrica. 2023;94(3):379–385. doi:10.32641/andespediatr.v94i3.4417
23. Wang X, Li S, Huo D, Li C, Zhang Q, Wang X. Case series of bacteremia associated with probiotic use in children after cardiac surgery, China. Emerging Infectious Diseases. 2026;32(1):28–33. doi:10.3201/eid3201.250298
24. Doron SI, Hibberd PL, Gorbach SL. Probiotics for prevention of antibiotic-associated diarrhea. Journal of Clinical Gastroenterology. 2008;42(Suppl 2):S58–S63. doi:10.1097/MCG.0b013e3181618ab7

This article is for general information only and is not a substitute for medical advice.